Printed paper and board: Priority setting strategy for toxicological assessment

Similar documents
GENOTOXIC SUBSTANCES IN PRINTED PAPER AND BOARD FOOD CONTACT MATERIALS

Mutagenic impurities: predicting alerting structures using in silico tools

Leadscope Model Applier and the ICH M7 Impurities Guidelines Frequently Asked Questions

Use of (Q)SAR to Evaluate Potential Genotoxic Impurities

Joint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO)

Deputy Director General of Enterprise and Industry DG. Global Cooperation on alternatives (3Rs) to animal testing

Questions and answers on the 'Guideline on the limits of genotoxic impurities'

EFSA Network of the Food Ingredients and Packaging (FIP) Unit on Food Contact Materials (FCM)

Generics Perspective: Success Strategies for Genotoxic Impurity Identification, Assessment and Control

Evaluation of (Q)SAR models for the prediction of mutagenicity potential

Food Contact Materials gaps to be addressed the roadmap excercise

Committed since 2002 to ensuring that Europe s food is safe. David Gott. Chair & Rapporteur - WG Guidance on Food Additives

In silico strategies to assess potentially mutagenic impurities under ICH M7

Risk Management under the Chemicals Management Plan

COMMISSION REGULATION (EU) / of

MEMORANDUM ON THE USE OF IN SILICO METHODS FOR ASSESSMENT OF CHEMICAL HAZARD

Structure and content of an IMPD. What is required for first into man trial?

Threshold of Toxicological Concern Initiatives for Medical Devices Richard Hutchinson, DVM, PhD, DABT J&J Global Surgery Group.

Implementation of toxicological data from other legal provisions (e.g. REACH) An industry perspective

of the TTC Douglas J Ball, MS, DABT

Nexus 2.2: Overview. Dr Nicholas Marchetti Product Manager Dr Adrian Fowkes Senior Scientist

Evaluation and Control of Genotoxic Impurities in Active Pharmaceutical Ingredients

Technical Notes for Guidance. on the assessment of technical equivalence of substances regulated under Directive 98/8/EC

QSAR and Read-Across Approaches using in silico Tools in Food Ingredient/Contaminant Safety Assessments at the U.S. Food & Drug Administration

Expert decision support software for predicting the metabolic fate of chemicals in mammals.

Expert decision support software for predicting the forced degradation pathways of organic compounds

Printing Inks in the Council of Europe

Understanding the requirements of EU food contact legislation

Toxicological studies of impurities and degradation products: in silico Methodologies as a safety assessment tool

In silico strategies to assess potentially mutagenic impurities under ICH M7

Acceptance of New Technology. Richard Phillips, ExxonMobil Petroleum & Chemical CEFIC LRI 11th Annual Workshop, 19 November 2009

Non-clinical Assessment Requirements


evaluates aapproximately

Overview on legislation and scientific approaches for risk assessment of mixtures as EuroMix contribution

REGULATORY ASSURANCE R&D SUPPORT

Impact factor: 3.958/ICV: 4.10 ISSN:

What can be done from regulatory side?

Sicurezza Alimentare: Le Sfide per i Produttori di Adesivi

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)

David Owen Shell Chemicals Ltd ISRTP Workshop, Baltimore November 2005

Sarah Nexus: Strain Information

Practical Challenges for Food Contact Materials (FCM) Stakeholders: A Regulatory View

DISCOVER OUR SEGMENT REGULATORY SCIENCE

S2(R1) Revision of the Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use

Safety Assessment in the 21 st Century

Guideline on the non-clinical requirements for radiopharmaceuticals

Get ready for Meeting your information requirements. 11 th Stakeholder s Day. 25 May 2016

Chinese Chemicals Regulation and the influence from EU REACH

Scientifically Robust. Expert Software. Improving efficiency and aiding regulatory submission for over 30 years

EN SANCO/2006/ EN EN

Public Consultation in relation to the REACH REFIT evaluation

Derivation and Justification of Safety Thresholds

Setting Limits in Shared Facilities

OECD QSAR Toolbox Version 3.1

The use of integrated in silico solutions under the proposed ICH M7 guidelines

Alternative Testverfahren und intelligente Teststrategien Position der EU-Kommission. Thomas Hartung & ECVAM Team.

The European partnership for alternative approaches to animal testing

IMPURITIES IN NEW DRUG PRODUCTS

Ames Data Submissions and Other Qualification Data for Impurities in Drug Substances

The WHO Framework for Combined Exposures and MOA/AOP Analysis; Implications for Euromix. Euromix Kick Off Meeting

Safety Qualification Process and Application of Thresholds. Jim Blanchard PQRI L&E Toxicology Subgroup Principal Scientist Aradigm

Replacement of animal testing with new approach methodologies

Regulatory expectations on impurities in drug substances - Pavia, October 2, Luisa Torchio Euticals SpA

Preclinical studies needed in the development of human pharmaceutical drugs role of toxicology and risk assessment

EFSA Guidance on the Submission of a. Evaluation: Toxicological data

The OECD activities on biocides and IATA

Regulatory compliance in Non-Clinical development

NIAS: The new challenges for safety assessment of Food Contact Materials. Dr. Thomas Gude

SME Issues. webinar, 02 July 2013, 2pm BST

REACH 2018 Steps to a Successful Registration. Thursday, October 8, 2015

OVERVIEW OF THE OECD PROJECT ON ASSESSMENT OF COMBINED EXPOSURES TO MULTIPLE CHEMICALS

Drug Impurities: The Good, Bad and Ugly

Toxicology for the future research, development and education for chemical safety Welcome!

SWISS ORDINANCE ON MATERIALS AND ARTICLES IN CONTACT WITH FOOD (SR ) Permitted Substances for Packaging Inks. Questions & Answers

Computational prediction of toxicity

Guidance for Setting Occupational Exposure Limits: Emphasis on Data-Poor Substances

ICH S9 guideline on nonclinical evaluation for anticancer pharmaceuticals - questions and answers

Predicting Metabolites

An ASEAN guidance document for evaluating the safety of botanical. [Version ] Botanical Safety Assessment.

Background document for 4,4 -Diaminodiphenylmethane (MDA)

Coatings in NL. Regulation and risk assessment of Coating as FCM in The Netherlands. Bianca van de Ven RIVM

Endocrine discuptors under REACH

Non-clinical documentation Overview of Requirements

Strategies for grouping chemicals to fill data gaps to assess genetic toxicity and genotoxic carcinogenicity

Lhasa Limited Collaborative Data & Knowledge Sharing

Putting the Criteria into Practice

EPAA 3Rs Science Award 2012

Workshop on Food Contact Material legislation in the EU

Dosing for Controlled Exposure (DoCE): Dosing strategies for characterising in vitro dose-responses with increased relevance for in vivo extrapolation

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

Tox21: Opportunities& Challenges. Richard A. Becker Ph.D., DABT American Chemistry Council

REACH Review: Industry activities and views

Guideline on assessment and control of DNA reactive (mutagenic) impurities in veterinary medicinal products

REACH 2018 Registration Deadline

Adoption by CVMP for release for consultation 11 November End of consultation (deadline for comments) 31 May 2010

2017 AAM CMC Workshop

MODULE 3 Preclinical safety May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

Medical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark

TECHNICALS LEVEL APPLIED SCIENCE

Transcription:

Printed paper and board: Priority setting strategy for toxicological assessment M. Van Bossuyt 1,2, E. Van Hoeck 1, T. Vanhaecke 2, V. Rogiers 2* and B. Mertens 1* 1 Food, Medicines and Consumer Safety, Scientific Institute of Public Health, Brussels, Belgium 2 In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium * Equal contribution Food Packaging Forum Workshop Zürich, 5 October 2017

Overview Introduction Prioritisation strategy o Step 1: Database compilation o Step 2: In silico prediction o Step 3: Literature review o Step 4: In vitro experiments Conclusion and future perspectives

Overview Introduction Prioritisation strategy o Step 1: Database compilation o Step 2: In silico prediction o Step 3: Literature review o Step 4: In vitro experiments Conclusion and future perspectives

Food contact materials (FCM) Harmonised EU regulation

Printed paper and board FCM Widespread and frequent use No specific harmonised European regulation Thousands of non (recently) safety-evaluated substances Major cause of food contamination by FCM

Printed paper and board FCM Widespread and frequent use No specific harmonised European regulation Thousands of non (recently) safety-evaluated substances Major cause of food contamination by FCM PRIORITISATION based on genotoxic potential using alternative methods (in silico, in vitro)

Overview Introduction Prioritisation strategy o Step 1: Database compilation o Step 2: In silico prediction o Step 3: Literature review o Step 4: In vitro experiments Conclusion and future perspectives

Step 1: database compilation National legislations and European inventories on printing ink and paperboard compounds Swiss Ordinance RS 817.023.21 Annex 6 on printing inks (2013) Council of Europe resolution on paper and board (2009) European Food Safety Authority report on non-plastic FCM (2011) EU Regulation 10/2011 on plastic FCM (2016) 23% 77% Total: #6073 49% 28% Evaluated (#1383) Non-evaluated (#4690) Other e.g. polymers, mixtures, metals (#2967) Single substances (#1723) Van Bossuyt et al., Printed paper and board food contact materials as a potential source of food contamination. Reg. Tox. Pharm., 81 (2016) 10-19

Step 1: database compilation Step 2: in silico prediction (Quantitative) Structure-Activity Relationship ((Q)SAR) SAR: qualitative, based on structural alerts (SA) or expert rules QSAR: quantitative, based on mathematical formula ICH M7(R1) guideline on potentially genotoxic impurities in pharmaceuticals 1 SAR + 1 QSAR

Step 1: database compilation Step 2: in silico prediction Toxtree (SAR) VEGA (QSAR) Derek Nexus (SAR) Sarah Nexus (QSAR) v. 2.6.0 v. 1.1.1 v. 4.1.0 v. 1.2.0 Complementary Availability: free commercial Method: SAR QSAR Result representation and explanation: supporting evidence, experimental results, confidence score, applicability domain assessment,

Step 1: database compilation Required: Step 2: in silico prediction Simplified Molecular-Input Line-Entry System (SMILES) representation E.g. for aniline: C1=CC=C(C=C1)N aniline Can be retrieved from: - www.chemspider.com (Royal Society of Chemistry) - www.pubchem.ncbi.nlm.nih.gov/- (National Institutes of Health) - www.chem.sis.nlm.nih.gov/chemidplus/ (National Institutes of Health) -

Count Step 1: database compilation Step 2: in silico prediction INDIVIDUAL MODELS 2000 1800 1600 1400 77% 366 350 52% 255 229 104 69 13.5 up to 21% mutagenic 1200 1000 800 600 400 200 1357 758 615 1364 1425 Overlap? Smaller than expected Positive Undefined Negative 0 Toxtree VEGA Derek Sarah (Q)SAR

Step 1: database compilation Step 2: in silico prediction COMBINED MODELS 33% 6% 61% 12% 5% 8% 36% Total: #1723 Negative in all models (#572) Indeterminate (#1045) Negative in all, with restrictions (#619) Mutagenic in 1 (#204) Mutagenic in 2 (#93) Mutagenic in 3 (#129) Mutagenic in all models (#106) LOWEST PRIORITY MEDIUM PRIORITY HIGHEST PRIORITY Van Bossuyt et al., (Q)SAR tools for priority setting: A case study with printed paper and board food contact material substances. Food Chem. Tox., 102 (2017) 109-119 53 are training set compounds = in vitro mutagen

Step 1: database compilation Step 2: in silico prediction Step 3: Literature review Publically available in vitro and in vivo mutagenicity data OECD echemportal European Chemicals Agency website Cosmetic Ingredients database 5% 1% 14% 58% 10% 22% Total: #106 48% 17 training set mutagens 20 not available not used? 13 in vitro experiments Negative in vivo, official evaluation (#1) Negative in vitro, no official evaluation (#5) More data required (#61) Incomplete data (#11) No data (#50) Mutagenic in vitro, no in vivo follow-up (#16) Mutagenic in vivo (#23)

Step 1: database compilation Step 2: in silico prediction Step 3: Literature review Step 4: In vitro experiments In vitro gene mutation test in bacteria (=Ames test) ONGOING Mutagenicity of prioritised printed paper & board substances in S. typhimurium strain TA100 and TA98 23% 77% In vitro mutagen (#10) Ongoing (#3) Total: #13 So far, 10 out of 13 (77%) substances are mutagenic in vitro

Overview Introduction Prioritisation strategy o Step 1: Database compilation o Step 2: In silico prediction o Step 3: Literature review o Step 4: In vitro experiments Conclusion and future perspectives

A database was assembled including 6073 substances that can be used in printed paper and board FCM A battery of in silico (Q)SAR tools predicted 106 substances to be mutagenic in vitro Publically available literature data showed that minimum 39 of these are experimentally mutagenic, at least in vitro Substances without literature data are being tested in vitro and, so far, they are all mutagenic Future steps: Current usage? Migration? Prioritisation strategy can be extended to other substance types/groups

Thank you for your attention